SCHEMBL31056276

SCHEMBL31056276

C[Si](C)(C)C#Cc1cc(OCc2ccccc2)c(C2OCCO2)cc1Br

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 2/20 0.40
HTR2A P28223 1/20 0.40
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CCR5 P51681 1/20 0.35
SLC6A4 P31645 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34
MAOB P27338 2/20 0.34
HTR2B P41595 1/20 0.34
MAOA P21397 1/20 0.34
MAPK14 Q16539 1/20 0.34
KDM1A O60341 4/20 0.33
FNTA P49354 1/20 0.33
FNTB P49356 1/20 0.33
PGGT1B P53609 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31056705 0.84 PTGER1 (0.40) L3MBTL1
SCHEMBL26132995 0.81 MAPT (0.42) HTR2CMAPTMAPK1TDP1L3MBTL1
SCHEMBL31056266 0.80 HTR2C (0.46) HTR2CHTR2AMAPTMAPK1TDP1
SCHEMBL31056681 0.78 HTR2C (0.44) HTR2CHTR2AMAPTMAPK1TDP1
SCHEMBL31056082 0.77 KDM1A (0.45) HTR2CHTR2ACCR5SLC6A4MAOB
SCHEMBL589281 0.76 HTR2C (0.50) HTR2CHTR2AMAPTMAPK1TDP1
SCHEMBL8408319 0.74 SLC6A4 (0.52) HTR2CCCR5SLC6A4MAOBHTR2B
SCHEMBL23700129 0.74 HTR2C (0.48) HTR2CHTR2AMAPTMAPK1TDP1
SCHEMBL31056166 0.74 HTR2C (0.41) HTR2CHTR2AMAPTL3MBTL1CCR5
SCHEMBL23700093 0.74 HTR2C (0.47) HTR2CHTR2ACCR5SLC6A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024178390-A1 COVALENT MODIFIERS OF AKT1 AND USES THEREOF TERREMOTO BIOSCIENCES, INC. (US) 2024-08-29 WO disclosed